Amoxycillin clavulanate: an assessment after 15 years of clinical application (Q41520020)

2 October 2017

1 reference

title

Amoxycillin clavulanate: an assessment after 15 years of clinical application (English)

1 reference

2 October 2017

1 reference

Ball P

1

1 reference

PubMed ID

9210001

2 October 2017

Geddes A

series ordinal

2

1 reference

PubMed ID

9210001

2 October 2017

Rolinson G

series ordinal

3

1 reference

2 October 2017

1 June 1997

1 reference

2 October 2017

Journal of Chemotherapy

1 reference

2 October 2017

9

1 reference

2 October 2017

3

1 reference

2 October 2017

167-198

1 reference

Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria.

2 October 2017

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Efficacy of amoxicillin/clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Amoxycillin: a new semi-synthetic penicillin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Pharmacokinetics of amoxycillin and clavulanic acid in haemodialysis patients following intravenous administration of Augmentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

In vitro Protection of Group A Beta-Hemolytic Streptococci from Penicillin and Cephalothin by <i>Bacteroides fragilis</i>

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

In vitro activities of aztreonam, imipenem, and amoxycillin-clavulanate against ampicillin-resistant Haemophilus influenzae

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

The Second European Collaborative Study on the frequency of antimicrobial resistance in Haemophilus influenzae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Distribution of Streptococcus pneumoniae resistant to penicillin in the USA and in-vitro susceptibility to selected oral antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Pharmacokinetics and pharmacodynamics of antibiotics in otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Penetration of amoxycillin/clavulanic acid into bronchial mucosa with different dosing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Concentration of amoxycillin and clavulanate in lung compartments in adults without pulmonary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Novel beta-lactamases in amoxycillin-resistant Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Pharmacokinetics of clavulanic acid, given in combination with amoxycillin, in volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

beta-Lactamase of Pseudomonas pseudomallei and its contribution to antibiotic resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Antimicrobial susceptibility of Haemophilus ducreyi

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Bactericidal effects of co-amoxiclav (amoxycillin clavulanic acid) against a Legionella pneumophila pneumonia in the immunocompromised weanling rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium fortuitum and Mycobacterium chelonei to augmentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Randomized comparative study of amoxicillin-clavulanic acid and co-trimoxazole in the treatment of acute urinary tract infections in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Prospective comparison of amoxicillin-clavulanic acid and cefaclor in treatment of uncomplicated urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Comparative study of amoxicillin-clavulanic acid and cephalexin in the treatment of bacteriuria during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Comparative study of cephradine and amoxicillin-clavulanate in the treatment of recurrent urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Treatment of gentamicin-resistant Klebsiella urinary tract infections with cephradine, augmentin, cefuroxime and amikacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Amoxycillin/clavulanic acid: a review of its efficacy in over 38,500 patients from 1979 to 1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Double-blind randomised trial of co-amoxiclav versus placebo for persistent otitis media with effusion in general practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Evaluation of amoxicillin clavulanate twice daily versus thrice daily in the treatment of otitis media in children. Danish-Swedish Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Eradication of group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Treatment of patients with acute recurrent tonsillitis due to group A beta-haemolytic streptococci: a prospective randomized study comparing penicillin and amoxycillin/clavulanate potassium

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Sequential intravenous-oral amoxycillin/clavulanate (Augmentin) therapy in paediatric hospital practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

An open, comparative evaluation of amoxycillin and amoxycillin plus clavulanic acid ('Augmentin') in the treatment of bacterial pneumonia in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Amoxicillin-clavulanic acid in the treatment of lower respiratory tract infections caused by beta-lactamase-positive Haemophilus influenzae and Branhamella catarrhalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Comparison of amoxycillin/clavulanate with amoxycillin in children and adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Augmentin in acute exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

A combination of amoxicillin and clavulanic acid in the treatment of respiratory tract infections caused by amoxicillin-resistant haemophilus influenzae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Metronidazole and Augmentin in the prevention of sepsis after appendicectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Single-dose clavulanate-potentiated amoxycillin versus three-dose cefotaxime in the prevention of wound infection following elective cholecystectomy: a prospective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Good antimicrobial prescribing. Clinical uses of penicillins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Antibiotic prophylaxis against postpartum endometritis after vaginal delivery: a prospective randomized comparison between Amox-CA (Augmentin) and abstention

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Antimicrobial prophylaxis in hysterectomies: a double-blind, randomized, comparative study of a single dose of piperacillin (2 g) versus a single dose of amoxicillin-clavulanic acid (2.2 g).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

A prospective randomized study comparing amoxycillin/clavulanate with cefuroxime plus metronidazole for perioperative prophylaxis in gynaecological surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Amoxycillin/clavulanic acid (augmentin) compared with triple drug therapy for pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Bite wounds and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Therapy with newer oral beta-lactam and quinolone agents for infections of the skin and skin structures: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Double-blind comparative study of two dosage regimens of cefaclor and amoxicillin-clavulanic acid in the outpatient treatment of soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Outpatient therapy of bite wounds. Demographic data, bacteriology, and a prospective, randomized trial of amoxicillin/clavulanic acid versus penicillin +/- dicloxacillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1997.9.3.167

21 January 2018

Identifiers

DOI

10.1179/JOC.1997.9.3.167

1 reference

2 October 2017

1 reference

PubMed ID

9210001